Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The Veteran's JAK2 V617F positive myeloproliferative neoplasm (primary myelofibrosis) is considered to have been caused by in-service exposure to benzene and other chemicals.

The deciding factor: The Board found the evidence equally weighted, favoring the Veteran's claim that his service-connected condition was aggravated by in-service chemical exposure.

Claimed conditions
JAK2 V617F positive myeloproliferative neoplasm (primary myelofibrosis)
How they argued it
Aggravation of a pre-existing condition
Exposure basis
Burn pits / airborne hazards
Rating assigned
None in this decision
Decision date
September 17, 2018
Citation
18135865

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 18135865.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.